Trajan Group Holdings Ltd. (TRJNF)
0.40
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 61.02M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -20.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 0.5579 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Trajan Group Holdings Ltd. engages in the development and manufacture of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. It operates through Analytical Products and Life Science Solutions segments. The Analytical Products segment designs, manufactures, distributes, and sells Analytical components and consumables. The Life Science Solutions segment is involved in the sale of pathology, automation workflow solutions, micro sampling devices, testing, and data analysis. The company was founded by Stephen Andrew Tomisich and Angela Tomisich on August 11, 2011 and is headquartered in Ringwood, Australia. |
| URL | http://www.trajanscimed.com |
| Investor Relations URL | N/A |
| HQ State/Province | Victoria (VIC) |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Trajan Group Holdings Ltd. engages in the development and manufacture of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. It operates through Analytical Products and Life Science Solutions segments. The Analytical Products segment designs, manufactures, distributes, and sells Analytical components and consumables. The Life Science Solutions segment is involved in the sale of pathology, automation workflow solutions, micro sampling devices, testing, and data analysis. The company was founded by Stephen Andrew Tomisich and Angela Tomisich on August 11, 2011 and is headquartered in Ringwood, Australia. |
| URL | http://www.trajanscimed.com |
| Investor Relations URL | N/A |
| HQ State/Province | Victoria (VIC) |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |